• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by IRIDEX Corporation

    6/13/25 5:12:55 PM ET
    $IRIX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $IRIX alert in real time by email
    S-8 1 irix_-_2025_s-8_06.13.20.htm S-8 S-8

     

    As filed with the Securities and Exchange Commission on June 13, 2025

    Registration No. 333-

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    ____________________________

    FORM S‑8

    REGISTRATION STATEMENT

    UNDER

    THE SECURITIES ACT OF 1933

    ____________________________

    IRIDEX CORPORATION

    (Exact name of Registrant as specified in its charter)

    ____________________________

     

    Delaware

     

    77-0210467

    (State or other jurisdiction of

    incorporation or organization)

     

    (I.R.S. Employer

    Identification Number)

     

     

     

    1212 Terra Bella Avenue

    Mountain View, California

     

    94043

    (Address of Principal Executive Offices)

     

    (Zip Code)

     

    ____________________________

    2008 EQUITY INCENTIVE PLAN, AS AMENDED

    (Full title of the plans)

    ____________________________

    Patrick Mercer

    President, Chief Executive Officer, and Chief Operating Officer

    IRIDEX Corporation

    1212 Terra Bella Avenue

    Mountain View, California 94043

    (Name and address of agent for service)

    (650) 940-4700

    (Telephone number, including area code, of agent for service)

    ____________________________

    Copies to:

     

    Philip H. Oettinger

    Wilson Sonsini Goodrich & Rosati

    Professional Corporation

    650 Page Mill Road

    Palo Alto, California 94304-1050

    (650) 493-9300

    Romeo R. Dizon
    Chief Financial Officer
    IRIDEX Corporation
    1212 Terra Bella Avenue
    Mountain View, California, 94043
    (650) 940-4700

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     

    Large accelerated filer ☐

     

    Accelerated filer ☐

     

     

    Non-accelerated filer ☒

     

    Smaller reporting company ☒

     

     

     

     

    Emerging growth company ☐

     

    ____________________________

    If an emerging growth company, indicate by check mark if registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

     


     

    EXPLANATORY NOTE

     

    This Registration Statement on Form S-8 (the “Registration Statement”) registers additional shares of common stock of IRIDEX Corporation (the “Registrant”) reserved for issuance under the Registrant’s 2008 Equity Incentive Plan, as amended.

     

    PART I

    INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS

     

    The information specified in Item 1 and Item 2 of Part I of Form S-8 is omitted from this Registration Statement in accordance with the provisions of Rule 428 under the Securities Act of 1933, as amended (the “Securities Act”), and the introductory note to Part I of Form S-8. The documents containing the information specified in Part I of Form S-8 will be delivered to the participants in the equity benefit plan covered by this Registration Statement as specified by Rule 428(b)(1) under the Securities Act.

     

    PART II

    INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

    Item 3. Incorporation of Documents by Reference.

    The Registrant hereby incorporates by reference into this Registration Statement the following documents previously filed with the Securities and Exchange Commission (the “Commission”):

    (1) The Registrant’s Annual Report on Form 10-K for the fiscal year ended December 28, 2024, filed with the Commission on March 27, 2025 pursuant to Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”);

    (2) The Registrant’s Quarterly Report on Form 10-Q for the quarterly period ended March 29, 2025, filed with the Commission on May 13, 2025, pursuant to Section 13 of the Exchange Act;

    (3) All other reports filed pursuant to Section 13(a) or 15(d) of the Exchange Act since the end of the fiscal year covered by the Registrant’s Annual Report referred to in (1) above (other than information in any current report on Form 8-K deemed to have been furnished and not filed in accordance with the rules of the Commission and, except as may be noted in any such Form 8-K, exhibits filed on such Form 8-K that are related to such information); and

     

    (4) The description of the Registrant’s common stock contained in Exhibit 4.3 of the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 28, 2019, filed with the Commission on March 13, 2020, including any amendment or report filed for the purpose of updating such description.

     

     


     

    All documents filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act on or after the date of this Registration Statement and prior to the filing of a post-effective amendment to this Registration Statement that indicates that all securities offered have been sold or that deregisters all securities then remaining unsold shall be deemed to be incorporated by reference in this Registration Statement and to be part hereof from the date of filing of such documents; provided, however, that documents or information deemed to have been furnished and not filed in accordance with the rules of the Commission shall not be deemed incorporated by reference into this Registration Statement. Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any subsequently filed document which also is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

    Item 4. Description of Securities.

    Not applicable.

    Item 5. Interests of Named Experts and Counsel.

    Not applicable.

    Item 6. Indemnification of Directors and Officers.

    Section 145 of the General Corporation Law of the State of Delaware (the “DGCL”) provides that a corporation may indemnify any person made a party to an action by reason of the fact that he or she was a director, executive officer, employee or agent of the corporation or is or was serving at the request of a corporation against expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by him or her in connection with such action if he or she acted in good faith and in a manner he or she reasonably believed to be in, or not opposed to, the best interests of the corporation and, with respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful, except that, in the case of an action by or in right of the corporation, no indemnification may generally be made in respect of any claim as to which such person is adjudged to be liable to the corporation.

    As permitted by Section 102(b)(7) of the DGCL, the Registrant’s amended and restated certificate of incorporation (the “Charter”) includes provisions that eliminate the personal liability of its directors and officers for monetary damages for breach of their fiduciary duty as directors and officers. The Charter also provides that no amendment or repeal of such provision shall apply to or have any effect on the right to indemnification permitted thereunder with respect to claims arising from acts or omissions occurring in whole or in part before the effective date of such amendment or repeal whether asserted before or after such amendment or repeal.

    The Registrant’s amended and restated bylaws (the “Bylaws”) provide for the indemnification of officers, directors and third parties acting on behalf of the Registrant if such person acted in good faith and in a manner reasonably believed to be in and not opposed to the best interest of the Registrant, and, with respect to any criminal action or proceeding, the indemnified party had no reason to believe his or her conduct was unlawful. The Registrant

     


     

    has entered into indemnification agreements with each of its directors and executive officers and intends to enter into indemnification agreements with any new directors and executive officers in the future.

    The Registrant carries officer and director liability insurance with respect to certain matters, including matters arising under the Securities Act.

    See also the undertakings set out in response to Item 9 herein.
     

    Item 7. Exemption from Registration Claimed.

    Not applicable.

    Item 8. Exhibits.

    The following exhibits are filed with or incorporated by reference into this Registration Statement:

     

     

     

     

     

     

     

     

     

    Exhibit No.

     

    Description

    Incorporated by Reference

    Filed Herewith

     

     

     

    Form

    File No.

    Exhibit

    Filing Date

    4.1

     

     

    Description of Capital Stock.

    10-K

    000-27598

    4.3

    March 13, 2020

     

    5.1

     

     

    Opinion of Wilson Sonsini Goodrich & Rosati, Professional Corporation.

     

     

     

     

    X

    23.1

     

     

    Consent of BPM LLP, Independent Registered Public Accounting Firm.

     

     

     

     

    X

    23.2

     

     

    Consent of Wilson Sonsini Goodrich & Rosati, Professional Corporation (see Exhibit 5.1).

     

     

     

     

    X

    24.1

     

     

    Power of Attorney (included on the signature page hereto).

     

     

     

     

    X

    99.1*

     

     

    2008 Equity Incentive Plan, as amended.

    8-K

    000-27598

    10.1

    June 13, 2025

     

    99.2*

     

     

    Form of 2008 Equity Incentive Plan Option Agreement.

    S-8

    333-155598

    99.1

    November 21. 2008

     

    99.3*

     

     

    Form of Stand-Alone Stock Option Agreement.

    SC TO-I

    005-48169

    99.(d)(5)

    July 30, 2009

     

    99.4*

     

     

    Form of 2008 Equity Incentive Plan Restricted Stock Award Agreement.

    10-Q

    000-27598

    10.1

    August 4, 2011

     

    99.5*

     

     

    Form of Stock 2008 Equity Incentive Plan Restricted Stock Unit Award Agreement.

    10-Q

    000-27598

    10.2

    August 4, 2011

     

    107

     

     

    Filing Fee Table.

     

     

     

     

    X

     

    *Indicates management contract or compensatory plan, contract or arrangement.

     


     

    Item 9. Undertakings.

    A. The undersigned Registrant hereby undertakes:

    (1) To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:

    (i) to include any prospectus required by Section 10(a)(3) of the Securities Act;

    (ii) to reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement; and

    (iii) to include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement.

    Provided, however, that paragraphs (A)(1)(i) and (A)(1)(ii) above do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in this Registration Statement.

    (2) For the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

    (3) It will remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

    B. The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in this Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

     


     

    C. Insofar as indemnification for liabilities arising under the Securities Act may be permitted to the Registrant’s directors, officers and controlling persons pursuant to applicable law, the Registrant’s Charter, Bylaws, rights agreements or indemnification agreements, the Registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of in a successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered hereunder, the Registrant will, unless in the opinion of the Registrant’s counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question of whether such indemnification by the Registrant is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

     

     

     


     

    SIGNATURES

    Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Mountain View, State of California, on June 13, 2025.

     

     

    IRIDEX CORPORATION

     

     

    By:

    /s/ Patrick Mercer

     

    Patrick Mercer

     

    President and Chief Executive Officer

     

     

    By:

    /s/ Romeo R. Dizon

     

    Romeo R, Dizon

     

    Chief Financial Officer

     

    POWER OF ATTORNEY

    KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Patrick Mercer and Romeo R. Dizon, and each of them acting individually, as his or her true and lawful attorneys-in-fact and agents, with full power of each to act alone, with full powers of substitution and resubstitution, for him or her in his or her name, place and stead, in any and all capacities to sign any and all amendments to this Registration Statement on Form S-8 (including post-effective amendments), and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, with full power of each to act alone, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully for all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or his, her or their substitutes, may lawfully do or cause to be done by virtue hereof.

    Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed below by the following persons in the capacities and on the date indicated.

     


     

    Signature

     

    Title

     

    Date

     

     

     

     

     

    /s/ Patrick Mercer

     

    President, Chief Executive Officer, Chief Operating Officer and Director

     (Principal Executive Officer)

     

    June 13, 2025

    Patrick Mercer

     

     

     

     

     

     

     

    /s/ Romeo R. Dizon

     

    Chief Financial Officer

    (Principal Financial Officer and Principal Accounting Officer)

     

    June 13, 2025

    Romeo R. Dizon

     

     

     

     

     

     

     

    /s/ William Moore

     

    Director

     

    June 13, 2025

    William Moore

     

     

     

     

     

     

     

    /s/ Nick Chen

     

    Director

     

    June 13, 2025

    Nick Chen

     

     

     

     

     

     

     

    /s/ Beverly A. Huss

     

    Director

     

    June 13, 2025

    Beverly A. Huss

     

     

     

     

     

     

     

    /s/ Scott Shuda

     

    Chairperson of the Board of Directors

     

    June 13, 2025

    Scott Shuda

     

     

     

     


    Get the next $IRIX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $IRIX

    DatePrice TargetRatingAnalyst
    More analyst ratings